interaction between phytoconstituents and biological proteins plays a central role in determining pharmacological efficacy, bioavailability, and therapeutic specificity of plant-derived compounds. Recent advances in molecular biophysics and neuropharmacology suggest that these interactions are not solely governed by ligand–receptor complementarity but are significantly modulated by environmental chemical factors, including metallic cofactors and amphiphilic reagents. This paper investigates the modulatory behavior of such cofactors in influencing phytoconstituent–protein complex formation, with emphasis on neurobiological systems and protein conformational dynamics relevant to neurodegenerative disorders.

Metallic ions act as structural and catalytic mediators that influence protein folding landscapes, stabilize transient binding conformations, and alter electrostatic microenvironments critical for ligand association. Similarly, amphiphilic reagents, due to their dual hydrophilic–hydrophobic nature, modify membrane–protein interactions and enhance solubility-driven binding kinetics of phytochemicals. Drawing upon evidence from neurobiological modulation studies, including ultrasound-mediated neuromodulation, synaptic plasticity regulation, and protein aggregation pathways, this work integrates biochemical and biophysical perspectives to propose a unified model of cofactor-assisted phytoconstituent binding.

Key insights are derived from comparative analysis of neuroprotective phytochemical systems and experimental neuromodulation frameworks such as low-intensity ultrasound and magnetic stimulation, which indirectly highlight the importance of microenvironmental modulation in protein–ligand interactions (Fomenko et al., 2018; Dalecki, 2004). Furthermore, studies on Alzheimer’s disease models demonstrate that protein aggregation pathways, particularly those involving amyloid-beta and tau proteins, are highly sensitive to biochemical modulation (Li et al., 2020; Park, 2021).

The findings suggest that metallic cofactors and amphiphilic agents act as dynamic regulators rather than passive participants in phytoconstituent–protein complex formation. This regulatory role has implications for drug design, neurotherapeutics, and phytopharmacology, particularly in disorders characterized by protein misfolding and synaptic dysfunction. The paper concludes by proposing a mechanistic framework integrating biochemical modulation, protein energetics, and phytochemical reactivity, offering new directions for targeted therapeutic development.

Phytoconstituent–protein interaction, metallic cofactors, amphiphilic reagents, protein folding dynamics, neuropharmacology, Alzheimer’s disease, ligand binding modulation, bioinorganic chemistry, protein aggregation, neurotherapeutics

J. B. Aimone, W. Deng, and F. H. Gage, “Resolving new memories: A critical look at the dentate gyrus, adult neurogenesis, and pattern separation,” Neuron, vol. 70, no. 4, pp. 589–596, May 2011.

A. Bystritsky, “A review of low-intensity focused ultrasound pulsation,” Brain Stimulation, vol. 4, no. 3, pp. 125–136, Jul. 2011.

C.-Z. Yang, “Neuroprotective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice,” Cell Death Discovery, vol. 9, no. 1, p. 15, Jan. 2023.

D. Dalecki, “Mechanical bioeffects of ultrasound,” Annu. Rev. Biomed. Eng., vol. 6, no. 1, pp. 229–248, Aug. 2004.

J. Diniz-Filho, T. B. Ludermir, “Modeling Modulatory Aspects in Association Processes. In (French and Sougne), Perspectives in Neural Computing. Connectionist Models of Development and Evolution. SpringerVerlag, London, 2001, p. 63–72.

A. Fomenko, C. Neudorfer, R. F. Dallapiazza, S. K. Kalia, and A. M. Lozano, “Low-intensity ultrasound neuromodulation: An overview of mechanisms and emerging human applications,” Brain Stimulation, vol. 11, no. 6, pp. 1209–1217, Nov. 2018.

J. J. Gallagher, A. M. Minogue, and M. A. Lynch, “Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased aβ accumulation and microglial activation,” Neurodegenerative Diseases, vol. 11, no. 1, pp. 33–41, 2013.

S.-L. Huang, C.-W. Chang, Y.-H. Lee, and F.-Y. Yang, “Protective effect of low-intensity pulsed ultrasound on memory impairment and brain damage in a rat model of vascular dementia,” Radiology, vol. 282, no. 1, pp. 113–122, Jan. 2017.

J. P. Johansen, C. K. Cain, L. E. Ostroff, and J. E. LeDoux, “Molecular mechanisms of fear learning and memory,” Cell, vol. 147, no. 4, p. 948, Nov. 2011.

E. M. Khedr, “A double-blind randomized clinical trial on the efficacy of cortical direct current stimulation for the treatment of Alzheimer’s disease,” Frontiers Aging Neurosci., vol. 6, p. 275, Oct. 2014.

E. Korner, G. Matsumoto, M. Kawato, “Organisation of Computation in Brain-like Systems. Neural Networks, 12 (7-8): 943–1206, Special Edition 1999.

E. Kumari, Y. Shang, Z. Cheng, and T. Zhang, “U1 snRNA over-expression affects neural oscillations and short-term memory deficits in mice,” Cognit. Neurodyn., vol. 13, no. 4, pp. 313–323, Mar. 2019.

K. Li, Y. Jiang, G. Li, T. Liu, and Z. Yang, “Novel multitarget directed tacrine hybrids as anti-Alzheimer’s compounds improved synaptic plasticity and cognitive impairment in APP/PS1 transgenic mice,” ACS Chem. Neurosci., vol. 11, no. 24, pp. 4316–4328, Dec. 2020.

E. Landhuis, “Ultrasound for the brain,” Nature, vol. 551, no. 7679, pp. 257–259, 7679.

P. J. Lang, M. M. Bradley, B. N. Cuthbert, “Emotion, Motivation, and Anxiety: Brain Mechanisms and Psychophysiology. Biol. Psychiatry, 44 : 1248–1263, 1998.

A. Leparulo, M. Bisio, N. Redolfi, T. Pozzan, S. Vassanelli, and C. Fasolato, “Accelerated aging characterizes the early stage of Alzheimer’s disease,” Cells, vol. 11, no. 2, p. 238, Jan. 2022.

G. Leinenga, “Transcriptional signature in microglia isolated from an Alzheimer’s disease mouse model treated with scanning ultrasound,” Bioeng. Transl. Med., vol. 8, no. 1, Jan. 2023, Art. no. e10329.

W.-T. Lin, R.-C. Chen, W.-W. Lu, S.-H. Liu, and F.-Y. Yang, “Protective effects of low-intensity pulsed ultrasound on aluminum-induced cerebral damage in Alzheimer’s disease rat model,” Sci. Rep., vol. 5, no. 1, p. 9671, Apr. 2015.

M. Nafea, M. Elharoun, M. M. Abd-Alhaseeb, and M. W. Helmy, “Leflunomide abrogates neuroinflammatory changes in a rat model of Alzheimer’s disease: The role of TNF-α/NF-κB/IL-1β axis inhibition,” Naunyn-Schmiedeberg’s Arch. Pharmacol., vol. 396, no. 3, pp. 485–498, Mar. 2023.

X. Niu, K. Yu, and B. He, “On the neuromodulatory pathways of the in vivo brain by means of transcranial focused ultrasound,” Current Opinion Biomed. Eng., vol. 8, pp. 61–69, Dec. 2018.

M. Park, “Effects of transcranial ultrasound stimulation pulsed at 40 Hz on β plaques and brain rhythms in 5XFAD mice,” Transl. Neurodegener., vol. 10, no. 1, p. 48, 2021.

K. Richetin, P. Petsophonsakul, L. Roybon, B. P. Guiard, and C. Rampon, “Differential alteration of hippocampal function and plasticity in females and males of the APPxPS1 mouse model of Alzheimer’s disease,” Neurobiol. Aging, vol. 57, pp. 220–231, Sep. 2017.

S. Zhou and G. Huang, “The biological activities of butyrylcholinesterase inhibitors,” Biomed. Pharmacotherapy, vol. 146, Feb. 2022, Art. no. 112556.

T. Tan, “Low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) reverses Aβ(1-42)-mediated memory deficits in rats,” Exp. Gerontol., vol. 48, no. 8, pp. 786–794, Aug. 2013.

P. Turriziani, “Low-frequency repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex enhances recognition memory in Alzheimer’s disease,” J. Alzheimer’s Disease, vol. 72, no. 2, pp. 613–622, Nov. 2019.

B. Voytek, M. D’Esposito, N. Crone, and R. T. Knight, “A method for event-related phase/amplitude coupling,” NeuroImage, vol. 64, pp. 416–424, Jan. 2013.

Y.-Y. Wang, “Long-term voluntary exercise inhibited AGE/RAGE and microglial activation and reduced the loss of dendritic spines in the hippocampi of APP/PS1 transgenic mice,” Experim. Neurol., vol. 363, May 2023, Art. no. 114371.

Y. Yuan, Z. Wang, M. Liu, and S. Shoham, “Cortical hemodynamic responses induced by low-intensity transcranial ultrasound stimulation of mouse cortex,” NeuroImage, vol. 211, May 2020, Art. no. 116597.

Y. Yuan, Z. Wang, X. Wang, J. Yan, M. Liu, and X. Li, “Low-intensity pulsed ultrasound stimulation induces coupling between ripple neural activity and hemodynamics in the mouse visual cortex,” Cerebral Cortex, vol. 29, no. 7, pp. 3220–3223, Jul. 2019.

Y. Yuan, Z. Zhao, Z. Wang, X. Wang, J. Yan, and X. Li, “The effect of low-intensity transcranial ultrasound stimulation on behavior in a mouse model of Parkinson’s disease induced by MPTP,” IEEE Trans. Neural Syst. Rehabil. Eng., vol. 28, no. 4, pp. 1017–1021, Apr. 2020.

M.-L. Lewicki, “A review of methods for spike sorting: The detection and classification of neural action potentials,” Network: Comput. Neural Syst., vol. 9, no. 4, pp. R53–R78, Nov. 1998.